Lipocine Inc. Annual Nonoperating Income (Expense) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Lipocine Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2022 to 2023.
  • Lipocine Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $412K, a 4.91% increase year-over-year.
  • Lipocine Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $1.24M.
  • Lipocine Inc. annual Nonoperating Income (Expense) for 2023 was $1.58M, a 16% increase from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.58M +$218K +16% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $1.36M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.